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Heavy use of drugs impacts of the daily activities of individuals in these activities. Several 
groups of investigators have indeed documented changes in cognitive performance by 
individuals who have a long history of chronic drug use. In the case of marijuana, a wealth 
of information suggests that heavy long-term use of the drug may have neurobehavioral 
consequences in some individuals. In humans, heavy cocaine use is accompanied by 
neuropathological changes that might serve as substrates for cognitive dysfunctions. 
Similarly, methamphetamine users suffer from cognitive abnormalities that may be con-
sequent to alterations in structures and functions. Here, we detail the evidence for these 
neuropsychological consequences. The review suggests that improving the care of our 
patients will necessarily depend on the better characterization of drug-induced cognitive 
phenotypes because they might inform the development of better pharmacological and 
behavioral interventions, with the goal of improving cognitive functions in these subsets 
of drug users.
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iNTRODUCTiON
Substance use disorders continue to be a major health concern worldwide. Chronic use of various 
drugs can impact brain structures and functions (1, 2). Use of these drugs may also be associated with 
both acute and chronic neuropsychological abnormalities (3). The present review summarizes some 
of the evidence documenting cognitive changes reported in drug users [with a focus on marijuana, 
cocaine, and methamphetamine (METH)]. We also discuss potential biological substrates for these 
observations. The neuropathological changes associated with the use of larger quantities of some 
of these drugs have been recently reviewed (1). In addition to having differential abuse liability, the 
use of some of these substances is also associated with differential pathoanatomic changes in the 
brain (1). There is also evidence that a history of substance use may also exacerbate pre-existing 
neuropsychological deficits (4) and comorbid neurological or psychiatric disorders (3). It is also clear 
that substance-related changes in neuropsychological functions may negatively impact activities of 
daily living, including ability to manage finances and/or holding on to jobs (5). A meta-analysis of 
METH users and cognition revealed that these individuals exhibited small-to-medium effect sizes 
for an association between neurocognitive impairment and employment (6). Cognitive domains 
associated with employment status included executive function, learning and memory, attention, 
and general intellectual ability (6). In the present review, we will discuss alterations that are linked 
to psychological and neural mechanisms that detect error signals and generate suitable behavioral 
TABLe 1 | Cognitive deficits reported in marijuana users.
Reference Cannabis dependence Cognitive findings
Solowij et al. (21, 22) Adult chronic users ↓ Attention
Pope et al. (13, 14) Adult heavy users (abstinent) ↓ Verbal memory
Adult moderate users 
(abstinent)
Bolla et al. (9) Adult abstinent users ↓ Verbal memory
↓ Visual memory
↓ Executive function
↓ Psychomotor speed
↓ Manual dexterity
Lyons et al. (23) Adult abstinent users ↓ General intelligence
Twin study
Medina et al. (24) Adolescent abstinent users ↓ Executive function
Hanson et al. (25) Adolescent abstinent users ↓ Verbal memory
↓ Attention
↓ Working memory
Battisti et al. (26) Adult chronic users ↓ Memory recall
Griffith-Lendering 
et al. (27)
Adult recreational users ↓ Inhibitory control
Meier et al. (28) Adolescent onset vs. adult 
onset
↓ IQ
Prospective study ↓ Working memory
↓ Reasoning
Solowij et al. (29) Adolescent chronic users ↓ Decision-making, 
increased impulsivity
Sewell et al. (30) Frequent and infrequent users ↓ Temporal processing 
in infrequent users
↓, Cognitive deficits.
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responses (7). Also discussed is the accumulated evidence of poor 
learning and memory, diminished executive functions, and risky 
decision-making in some individuals with a history of heavy drug 
use (8–11).
MARiJUANA USe
Marijuana is the most commonly used illicit substance (12). 
Investigations of cognitive functions in heavy marijuana users 
have recently documented poor performance in a number of 
cognitive subdomains. Some of these deficits appear to be related 
to frequency of drug use and can impact activities of daily living.
Neuropsychological Findings
Adult marijuana users suffer from changes measured in broad 
cognitive domains (13, 14). These include memory (9, 13, 14, 15), 
attention (16), decision-making (17), and psychomotor speed (9, 
18). Bolla et al. (9) reported that impairments observed in mari-
juana users could be measured in heavy users even after 28 days 
of forced abstinence during their participant stay on a closed 
research unit, with light use of marijuana not being associated 
with any significant decrements in performance (9). In a recent 
study, Colizzi et al. (19) studied whether functional variations in 
cannabinoid receptor 1 (CNR1) gene and marijuana exposure 
interact to modulate prefrontal functions and related behaviors. 
The authors suggested that deleterious effects of marijuana use 
may be more evident in individuals with specific genetic back-
grounds that might impact receptor expression (19). Additionally, 
it is important to note that, even if marijuana use during early 
adulthood is associated with cognitive impairments in selected 
domains, prolonged abstinence may promote improvement in 
performance (13, 14, 20). These data are summarized in Table 1.
Functional imaging studies comparing activation in both 
adult and adolescent chronic marijuana users to healthy controls 
during the performance of different cognitive tasks have reported 
that chronic marijuana users showed altered patterns of brain 
activity [Ref. (31–38), see Table 2]. There is also evidence to sug-
gest that heavy marijuana use may produce deficits on measures 
of decision-making and inhibitory control that persist for long 
periods of time (27). Among recreational marijuana users, lack 
of inhibitory control depends on contextual or situational factors, 
with loss of control being evident only when situations or tasks 
involve a motivational component (27). Also, poorer cognitive 
performance in areas of risk-taking, decision-making, and 
episodic memory may influence the degree to which marijuana 
users engage in risky behaviors with consequent negative health 
consequences (39). In addition, it has been reported that the main 
active ingredient in marijuana, delta-9 tetrahydrocannabinol 
(THC), can alter time perception by impairing time estimation 
and production in the seconds range (30). Temporal processing 
changes may have functional consequences because it is relevant 
to many everyday tasks, including driving (30).
Interestingly, although much more in-depth research remains 
to be done on this controversial issue, marijuana use during 
adolescence has been reported to increase the risk of developing 
psychotic disorders later in life (40). THC was also reported to 
induce acute psychotic symptoms in healthy individuals (41) 
and to increase the risk of psychotic disorders after long-term 
use (42). A recent study by Bhattacharyya et  al. (43) reported 
a significant relationship between the effects of THC on striatal 
activation, its effects on task performance, and appearance of 
positive psychotic symptoms, suggesting that THC might induce 
psychosis by influencing the neural substrate of attentional 
salience processing (43). Although more research is needed 
on this subject, there are plausible biochemical pathways that 
marijuana can impact to induced psychotic responses in some 
individuals. Specifically, the endocannabinoid system consists 
of cannabinoids receptors and endogenous cannabinoid ligands 
that interact with these receptors to impact the release of several 
neurotransmitters, including GABA, glutamate, and dopamine 
(44, 45). Therefore, it seems possible that exposure to marijuana-
based psychoactive substances during adolescence could 
negatively impact glutamatergic and GABAergic systems, with 
subsequent alterations of maturation processes of these systems, 
resulting in psychosis-like phenomena (46). The appearance of 
psychiatric disturbances might also depend on the exact dose, 
time windows during adolescence, and/or duration of drug 
exposure (24, 28, 40). Interestingly, hair analyses also revealed 
that marijuana users with high THC concentration were more 
likely to exhibit schizophrenia-like symptoms (47, 48). Some of 
the neuroimaging and cognitive changes reported in marijuana 
users appear to be moderated by gender (24, 49). These find-
ings highlight potential THC-induced neuroadaptations in the 
TABLe 2 | Functional neuroimaging studies on marijuana users performing cognitive tasks.
Reference Cannabis dependence Neuroimaging method Main findings
Block et al. (15) Adult chronic users PET ↓ Verbal memory
↓ Activation in PFC
↑ Activation in cerebellum
Bolla et al. (17) Adult abstinent users PET ↓ Decision-making
↓ Activation in DLPC and OFC
↑ Activation in cerebellum
Chang et al. (31) Adult chronic users fMRI ↓ Activation in cerebellum
Adult abstinent users Altered activation pattern in the attention network
Padula et al. (32) Adolescent abstinent users fMRI ↑ Activation in temporal gyrus, ACC
↓ Activation in thalamus, pulvinar, left temporal gyrus
Tapert et al. (33) Adolescent abstinent users fMRI ↑ Activation in DLPC, medial frontal cortex, parietal, and 
occipital gyrus
Schweinsburg et al. (34) Adolescent abstinent users fMRI ↑ Activation in parietal cortex
↓ Activation in DLPC and occipital cortex
Hester et al. (35) Adult chronic users fMRI ↓ Monitoring of interoceptive awareness
↓ Activation in insula, ACC, parietal, and frontal cortex
Abdullaev et al. (16) Young adult chronic users fMRI ↓ Attention
↑ Activation in PFC and parietal cortex
King et al. (18) Adult chronic users fMRI ↓ Psychomotor speed
↓ Activation in lingual gyrus
↑ Activation in frontal gyrus
Wesley et al. (37) Adult chronic users fMRI ↓ Decision-making
↓ Activation in cerebellum, ACC, parietal, and frontal 
cortex
Harding et al. (38) Adult chronic users fMRI ↑ Functional connectivity between PFC and 
occipitoparietal cortex
ACC, anterior cingulate cortex; DLPC, dorsal lateral prefrontal cortex; PFC, prefrontal cortex; ↓, decreased brain activation; ↑, increased brain activation; ↓, cognitive deficits.
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adolescent brain and support the importance of prevention 
and treatment of adolescent users (28). Nevertheless, this topic 
needs to be further investigated before any firm conclusion can 
be reached concerning the relationship of THC to psychosis and 
other psychiatric diseases.
COCAiNe USe
Although cocaine is a highly addictive agent, the vast majority 
of cocaine users do so recreationally over extended periods of 
time without developing dependence (50). Thus, documenting 
the potential cognitive effects of cocaine is an important public 
health issue because of its high prevalence in the general popula-
tion. Recent neurobehavioral studies have shown that cocaine 
heavy users show a number of cognitive decrements that may 
be secondary to cocaine-induced changes in brain structure and 
function (1). These cognitive deficits are detailed below.
Neuropsychological Findings
Heavy cocaine use is associated with decrements in performance 
in several cognitive domains [Ref. (51), detailed in Table  3]. 
These include problems in executive function, decision-making, 
increased impulsivity, abnormal visuoperception, abnormal 
psychomotor speed, impaired manual dexterity, poor verbal 
learning, and decrements in memory functions (8, 52–58). 
Additionally, cocaine users showed different patterns of brain 
activation while performing cognitive tasks [Ref. (59–67), see 
Table  4]. Chronic cocaine users show poor insight and judg-
ment, lack foresight, and are also disinhibited (68). These cogni-
tive changes are probably related to functional dysfunctions in 
the prefrontal cortex (69) since patients who suffer damage in 
this brain region manifest similar cognitive problems (70). This 
suggestion is supported by neuroimaging studies demonstrating 
hypofrontality in cocaine users performing tasks of attention and 
executive function (62, 71). From this perspective, the possibility 
that a core deficit in executive functions, such as context pro-
cessing, might contribute to the well-documented impairments 
in top-down control that are commonly associated with heavy 
cocaine use (72). In addition to those observations in chronic 
heavy cocaine users, subtle cognitive deficits have been reported 
in non-dependent, recreational cocaine users (50, 73–76).
There is a compelling evidence to suggest that cocaine-associ-
ated impairments in cognitive functioning might be secondary to 
cocaine-induced dysfunctions in dopaminergic systems (88–93). 
Cerebral hypoperfusion observed in the frontal and temporo-
parietal cortical areas of cocaine users (77, 94) may also subserve 
some of the observed cognitive deficits in these patients. These 
suggestions are consistent with the report of increased cerebral 
vascular resistance in cocaine users, abnormalities that lasted for, 
at least, 1 month of monitored abstinence (95).
In addition to specific deficits observed in cocaine users, these 
individuals may also suffer from psychosocial impairments. For 
TABLe 3 | Cognitive deficits reported in cocaine users.
Reference Cocaine dependence Cognitive findings
Ardila et al. (52) Adult chronic users ↓ Verbal memory
↓ Attention
O’Malley et al. (53) Adult chronic users ↓ Verbal memory
↓ Intelligence
↓ Verbal abilities
↓ Global 
neuropsychological 
functioning
Strickland et al. (77) Adult abstinent users ↓ Attention
↓ Visual memory
↓ Psychomotor speed
Hoff et al. (54) Adult abstinent users ↓ Spatial memory
↓ Cognitive flexibility
↓ Psychomotor speed
↑ Verbal abilities
Gillen et al. (55) Adult abstinent users ↓ Visual memory
↑ Visual motor speed
Robinson et al. (78) Adult chronic cocaine 
users
↓ Psychomotor 
functioning
Adult chronic 
cocaine + alcohol users
↓ Global 
neuropsychological 
functioning
Bolla et al. (8) Adult abstinent users ↓ Visuoperception
↓ Executive function
↓ Psychomotor speed
↓ Manual dexterity
Aharonovich et al. (79) Adult chronic users ↓ Attention
↓ Memory
↓ Spatial ability
Colzato et al. (73) Adult recreational users ↓ Inhibitory control
Woicik et al. (80) Adult chronic users ↓ Verbal memory
↓ Executive function
↓ Attention
Kalapatapu et al. (81) Young adult chronic users ↓ Psychomotor speed
Old adult chronic users ↓ Attention
↓ Memory
Madoz-Gúrpide et al. (82) Adult chronic users ↓ Executive function
Soar et al. (83) Adult recreational users ↓ Executive function
↓ Attention
Vonmoos et al. (84) Adult chronic users ↓ Executive function
Adult recreational users ↓ Attention
↓ Working memory
↓ Declarative memory
Winhusen et al. (68) Adult chronic users ↓ Executive function
↓ Inhibitory control
↑ Apathy
Jones et al. (72) Adult chronic users ↓ Context processing 
ability
Preller et al. (85) Adult chronic users ↓ Empathy
↓, Cognitive deficits; ↑, cognitive improvement; ↑, neurobehavioral symptoms.
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example, a recent study by Preller et al. (87) suggests a relationship 
between social cognition test outcomes in cocaine-dependent 
patients and real-life social functioning. Specifically, participants 
showing more empathy and better mental processing abilities 
had a larger social network. In addition, social network size 
was correlated with duration and amount of cocaine use. This 
suggests that cocaine use and the associated altered empathy 
and insight may have consequences in everyday life, including 
fewer social contacts and deprivation of emotional support (87). 
Additionally, Preller et  al. (85) also reported that individuals 
with cocaine dependence have blunted reward responses to 
social interactions as well as having reduced orbitofrontal cortex 
signals while performing a social cognition test. Taken together, 
these observations suggest that the treatment armamentarium 
may need to include interventions that boost more interactions 
of patients with other individuals in various social networks. This 
argument may explain, in part, why the affiliation-promoting 
peptide, oxytocin, may have beneficial effects in substance use 
treatment (96, 97). The possibility that social reward deficits 
might precede or be consequent to cocaine use needs to be 
investigated further (96).
In summary, although these cocaine-associated changes in 
cognitive functions have been well documented, their biological 
substrates have yet to be understood. Recent functional and struc-
tural imaging data provide ample support for impaired connec-
tivity in frontostriatal (4, 98) and striatal-insular (99) connections 
that serve as neuroanatomical and functional substrates for some 
of the cognitive deficits reported in cocaine using individuals. A 
clinical approach that takes into consideration the fact that some 
patients may actually suffer from cognitive impairments should 
stimulate investigations in order to provide more details on the 
basic substrates of cocaine use by humans (74).
MeTHAMPHeTAMiNe USe
Methamphetamine use is a serious public health problem (100). 
Long-term exposure to the drug has been shown to cause severe 
neurotoxic and neuropathological effects with consequent distur-
bances in several cognitive domains (1). These neuropsychologi-
cal impairments that can impact the daily lives of METH users 
are detailed below.
Neuropsychological Findings
Chronic METH users show mild signs of cognitive decline (10) 
affecting a broad range of cognitive functions [Ref. (5, 6, 101–112), 
see details in Table 5; but see also Ref. (113) for a counterargu-
ment]. A meta-analysis study by Scott et  al. (107) identified 
significant deficits of a medium magnitude in several different 
cognitive processes that are dependent on the functions of fronto-
striatal and limbic circuits. The affected domains include episodic 
memory, executive functions, complex information processing 
speed, and psychomotor functions (107). Additionally, METH 
use often results in irritability, agitation, and numerous other 
forms of psychiatric distress probably related to the myriad of 
interpersonal problems experienced by these patients (114, 115). 
METH dependence is also associated with complaints of cogni-
tive dysfunctions including memory problems and self-reported 
deficits in everyday functioning (110). Additionally, impulsive 
behaviors may exacerbate their psychosocial difficulties and 
promote maintenance of drug-seeking behaviors, especially, by 
those who use large amounts of the drug (116, 117). The nature 
and magnitude of cognitive deficits associated with chronic 
TABLe 4 | Functional neuroimaging studies on cocaine users performing cognitive tasks.
Reference Cocaine dependence Neuroimaging method Main findings
Goldstein et al. (59) Adult chronic users [(18)FDG PET] ↓ Visual memory
↓ Verbal memory
↓ Executive function
↓ Attention
Differential DLPC and ACC metabolism
Tucker et al. (60) Adult abstinent users SPECT ↓ Decision-making
↑ Hyperperfusion in frontal cingulate and superior frontal gyrus
Kübler et al. (61) Adult chronic users fMRI ↓ Visuospatial working memory
↓ Verbal working memory
↓ Activation in prefrontal cortex, ACC, thalamus, and striatal areas
Tomasi et al. (62) Adult chronic users fMRI ↓ Working memory
↓ Activation in thalamus and mesencephalon
↑ Activation in frontal/parietal cortex
↑ Deactivation in putamen, ACC, parahippocampal gyrus, and amygdala
Volkow et al. (86) Adult chronic users [(18)FDG PET] ↓ Metabolic activity in NAcc and OFC when inhibit craving
Hanlon et al. (63) Adult chronic users fMRI ↓ Sensorimotor abilities
↓ Functional laterality in cortical motor areas
Moeller et al. (64) Adult abstinent users fMRI ↓ Activation in PFC, striatum, and thalamus
↓ Activation in thalamus associated with poor treatment response
Volkow et al. (65) Adult male and female chronic 
users
[(18)FDG PET] ↑ Brain reactivity to cocaine-cues in women
↓ Activation in frontal, cingulate, and parietal cortex, thalamus, and 
midbrain in women
Camchong et al. (66) Adult chronic users fMRI ↓ Delay rewards
↓ Decision-making
↓ Learning
Altered connectivity within the ACC network, frontal hyperconnectivity
Barrós-Loscertales et al. 
(67)
Adult chronic users fMRI ↓ Activation in PFC
Preller et al. (87) Adult chronic users fMRI ↓ Activation in OFC
ACC, anterior cingulate cortex; DLPC, dorsal lateral prefrontal cortex; NAcc, nucleus accumbens; OFC, orbitofrontal cortex; PFC, prefrontal cortex; ↓, decreased brain activation; 
↑, increased brain activation; ↓, cognitive deficits.
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METH use increase the risk of poorer health outcomes, high-risk 
behaviors, treatment non-adherence, and repeated relapses (110, 
118). These adverse consequences might be secondary to poor 
executive function and memory deficits that may contribute to 
continuous drug-seeking behaviors (70). It needs to be noted that 
partial recovery of neuropsychological functioning and improve-
ment in affective distress can be achieved after a period of sus-
tained abstinence from METH (5). Hart et al. (113) have reviewed 
the literature and suggested that the deficits reported may be 
statistically but not clinically significant. In a follow-up analysis 
of similar data, Dean et al. (10) came to a different conclusion. 
These issues are important to clinicians who are responsible for 
the daily and/or long-term care of patients because small deficits 
may be of substantial importance when it comes to patients being 
able to follow instructions that would help them to participate in 
their own care, given the high rate of recidivism in that patient 
population (119, 120). Therefore, identifying patients with 
neuropsychological deficits would allow for the development 
of specific cognitive or pharmacological approaches that would 
benefit them.
Neuroimaging studies have documented several alterations in 
brain activation patterns induced by METH [Ref. (104, 121–128), 
see Table 6]. These studies reported decreased frontal activation 
associated with impaired decision-making (104) and cognitive 
control (127). Other brain regions sensitive to METH effects 
include the cingulate gyrus and insula (122, 128). METH users 
who showed impaired attention (122) and impaired cognitive 
control (128) exhibited abnormalities in these brain regions (see 
Table 6). It is worth mentioning that, in some cases, stimulant-
dependent patients report clinically significant neuropsychologi-
cal abnormalities prior to lifetime initiation of psychostimulant 
use (68).
Recovery of Neurocognitive Functioning 
and Treatment implications
Chronic use of several illicit drugs is associated with variable 
degrees of impaired cognitive functioning that shows different 
levels of improvement during sustained abstinence (3). Recovery 
from METH dependence is associated with improved perfor-
mance in tests of mental flexibility, attention, processing speed, 
verbal memory, fine motor functioning, and verbal fluency (5). 
Improvements in performance are also seen in abstinent marijuana 
users (13, 14). Moreover, Brewer et al. (131) found that activation 
in corticostriatal regions, linked to cognitive control, correlated 
with abstinence and cocaine-free urine toxicology (131). There 
was also an inverse correlation between prefrontal cortex activa-
tion and treatment retention (131), thus supporting the notion 
that identification of patients with cognitive deficits are important 
for the long-term care of these patients (3, 132). This suggestion 
is supported by the results of a very recent report that strength of 
craving for METH can be reduced by cognitive strategies (133). In 
TABLe 6 | Functional neuroimaging studies on methamphetamine users 
performing cognitive tasks.
Reference Methamphetamine 
dependence
Neuroimaging 
method
Main findings
Paulus et al. 
(104)
Adult abstinent users fMRI ↓ Decision-making
↓ Activation in PFC
Chang et al. 
(121)
Adult chronic users Structural MRI Larger globus 
pallidus and 
putamen
London 
et al. (122)
Adult abstinent users [(18)FDG PET] ↓ Attention
Differential 
activation in 
cingulate gyrus 
and the insula
Johanson 
et al. (123)
Adult abstinent users PET ↓ Memory
↓ Attention
↓ Information 
processing speed
↓ DAT and VMAT2 
in striatal regions
Monterosso 
et al. (124)
Adult abstinent users fMRI ↓ Decision-making
↓ Cortical 
efficiency in 
frontoparietal 
clusters
Payer et al. 
(129)
Adult abstinent users fMRI ↑ Activation in 
ACC
↓ Activation in PFC
Hoffman 
et al. (130)
Adult abstinent users fMRI ↑ Impulsivity
↓ Activation in 
caudate, DLPC, 
ACC
Salo et al. 
(127)
Adult abstinent users fMRI ↓ Cognitive control
↓ Activation in PFC
Nestor et al. 
(128)
Adult abstinent users fMRI ↓ Cognitive control
↓ Activation in 
motor cortex/
anterior cingulate 
gyrus, insular 
cortex
ACC, anterior cingulate cortex; DLPC, dorsal lateral prefrontal cortex; PFC, prefrontal 
cortex; ↓, decreased brain activation; ↑, increased brain activation; ↓, cognitive deficits; 
↑, cognitive improvement; ↑, neurobehavioral symptoms.
TABLe 5 | Cognitive deficits reported in methamphetamine users.
Reference Methamphetamine 
dependence
Cognitive findings
Simon et al. (101) Adult chronic users ↓ Attention
↓ Verbal memory
↓ Executive function
Simon et al. (102) Adult chronic users ↓ Psychomotor speed
↓ Attention
↓ Inhibitory control
Salo et al. (105) Adult abstinent users ↓ Cognitive inhibition
Simon et al. (103) Adult abstinent users ↓ Episodic memory
Adult abstinent users 
with relapse
Adult chronic users
Newton et al. 
(106)
Adult abstinent users ↓ Working memory
↓ Psychomotor speed
Scott et al. (107) Adult chronic users 
meta-analysis
↓ Executive function
↓ Verbal fluency
↓ Motor ability
↓ Verbal memory
↓ Language
↓ Visuo-constructional abilities
↓ Information processing speed
Rendell et al. (108) Adult abstinent users ↓ Executive function
↓ Working memory
↓ Retro and prospective memory
Henry et al. (109) Adult abstinent users ↓ Facial recognition
Henry et al. (110) Adult abstinent users ↓ Functioning everyday abilities
Iudicello et al. (5) Adult abstinent users, 
w or w/o relapse
↑ Global cognitive and affective 
improvements with sustained 
abstinenceLongitudinal study
Weber et al. (111) Adult abstinent users ↓ Global cognitive 
scores = predictor of 
unemployment 
Cattie et al. (112) Adult abstinent users ↑ Neurobehavioral symptoms
↓ Inhibition (self-reported)
↓ Executive function 
(self-reported)
↓, Cognitive deficits; ↑, cognitive improvement; ↑, neurobehavioral symptoms.
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addition, patients who participated in computer-assisted cogni-
tive behavioral therapy showed improved task performance and 
reduced task-related signal changes in several regions implicated 
in cognitive control, impulse control, and motivational salience, 
including the anterior cingulate and midbrain (134).
CONCLUSiON
Chronic use of illicit substances, including marijuana, cocaine, 
and METH, is associated with abnormal goal-directed behaviors 
that are thought to be the manifestations of altered cortico-
striatal-limbic circuits (2, 135). Nevertheless, the wealth of clini-
cal presentations, neuroimaging studies, and some pathological 
findings suggest that the biochemical and structural effects of 
chronic heavy use of drugs may reach beyond the boundaries 
of these reward circuits (1). The data reviewed here indicate 
that chronic use of illicit drugs is accompanied by moderate 
cognitive impairments in some patients. These observations 
may be related to functional and structural changes in various 
brain regions, including both cortical and subcortical regions of 
the human brain (1, 98, 136). In addition, it has been reported 
frontal deficits in psychostimulant-dependent patients reporting 
current clinically neurobehavioral abnormalities may be linked 
to pre-existing abnormalities (68). Because drug dependence 
develop over many months, it is likely that drug-related changes 
of behaviors may be modulated by some of these pathological 
phenomena in such a way as to significantly impact the clinical 
course of chronic use of these substances. Thus, impaired learn-
ing and memory functions might negatively impact the ability 
of a specific subset of patients to benefit from general treatment 
approaches. This inability may explain, in part, the high rate of 
recidivism in this patient population. This argument suggests that 
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